Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             26 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen Jain, Shilpa L.
1996
14 13 p. 1291-1297
7 p.
artikel
2 Annual influenza vaccination: immune response in patients over 10 years Gross, Peter A.
1996
14 13 p. 1280-1284
5 p.
artikel
3 An outbreak of vaccination panic D'Argenio, Paolo
1996
14 13 p. 1289-1290
2 p.
artikel
4 Aqueous-based microencapsulation enhances virus-specific humoral immune responses in mice after parenteral inoculation Moser, Charlotte A.
1996
14 13 p. 1235-1238
4 p.
artikel
5 Association of placental transfer of anti-Haemophilus influenzae type b polysaccharide antibodies with their V regions Park, M.K.
1996
14 13 p. 1219-1222
4 p.
artikel
6 Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations—III Aggerbeck, Henrik
1996
14 13 p. 1265-1272
8 p.
artikel
7 Calendar 1996
14 13 p. 1300-
1 p.
artikel
8 DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2 Bourne, Nigel
1996
14 13 p. 1230-1234
5 p.
artikel
9 Erratum 1996
14 13 p. 1298-
1 p.
artikel
10 Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine Tarr, Philip E.
1996
14 13 p. 1199-1204
6 p.
artikel
11 Human adenovirus type 5 vectors expressing rabies glycoprotein Yarosh, Oksana K.
1996
14 13 p. 1257-1264
8 p.
artikel
12 International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants Barnett, P.V.
1996
14 13 p. 1187-1198
12 p.
artikel
13 International meeting on the nucleic acid vaccines for the prevention of infectious disease and regulating nucleic acid (DNA) vaccines Spier, R.E.
1996
14 13 p. 1285-1288
4 p.
artikel
14 Modification of T-lymphocyte responsiveness without eliciting a superantigen-mediated response using Staphylococcus aureus TSST-1 superantigen derivative; useful for preventing and treating antigen-mediated diseases, such as toxic shock syndrome 1996
14 13 p. 1299-
1 p.
artikel
15 Modulation of the immune response; recombinant antigen preparation by CD21 ligand, CD19 ligand or C3d fusion protein gene expression in host cell; application in improved recombinant vaccine 1996
14 13 p. 1299-
1 p.
artikel
16 Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine 1996
14 13 p. 1299-
1 p.
artikel
17 Mutant viruses for vaccine production; herpes simplex virus-1 or -2 or adenovirus attenuation by deletion or antisense RNA expression for use as recombinant vaccine vector 1996
14 13 p. 1299-
1 p.
artikel
18 Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro Xing, Dorothy K.-L.
1996
14 13 p. 1205-1213
9 p.
artikel
19 Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy Kurikka, Sari
1996
14 13 p. 1239-1242
4 p.
artikel
20 Production of a genetically engineered inhibin vaccine Geary, T.W.
1996
14 13 p. 1273-1279
7 p.
artikel
21 Prospects for the use of new vaccines in developing countries: cost is not the only impediment Hausdorff, William P.
1996
14 13 p. 1179-1186
8 p.
artikel
22 Recombinant virus for enhancing immune response; recombinant vaccinia virus construction, for application as a recombinant vaccine, for cancer and microorganism and virus infection therapy 1996
14 13 p. 1299-
1 p.
artikel
23 Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60 Falsey, Ann R.
1996
14 13 p. 1214-1218
5 p.
artikel
24 Size effect on the antibody production induced by biodegradable microspheres containing antigen Nakaoka, Ryusuke
1996
14 13 p. 1251-1256
6 p.
artikel
25 Vaccination protects β 2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection Hildeman, David
1996
14 13 p. 1223-1229
7 p.
artikel
26 Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response Bishop, Sarah A.
1996
14 13 p. 1243-1250
8 p.
artikel
                             26 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland